Vista Pharmaceuticals Ltd.
Snapshot View

10.45 +0.07 ▲0.7%

26 July 2021, 09:42:00 A.M.
Volume: 1,203

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.vistapharmaceuticals.com
Financial Indicators
Market Cap 38.19 Cr.
Earnings per share (EPS) -0.51 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2021-03
Industry PE 35.17 Trailing Twelve Months Ending 2021-03
Book Value / Share 8.93 Trailing Twelve Months Ending 2021-03
Price to Book Value 1.16 Calculated using Price: 10.38
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 3.68 Cr. 36,793,908 Shares
FaceValue 2
Company Profile

Vista Pharmaceuticals Limited was incorporated on January 25,1991 under the Companies Act of 1956 with the Registrar of Companies Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. Vista Pharmaceuticals was incorporated by Dr. Dhananjaya Alli & his associates. The capital was subscribed by Vista Pharmaceuticals Inc., an Overseas Corporate Body promoted by them as a per the laws of State of New Jersy, United States of America.

The Company was in process of setting up a 100% EOU for manufcacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum.

Vista, the largest division of Torrent Pharmaceuticals Ltd, offers a range of products mainly in the therapeutic areas of gastrointestinal, pain management and anti-infective, catering to common ailments. This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+0.67%
1 Week
-7.60%
1 Month
-10.07%
3 Month
-28.08%
6 Month
-0.48%
1 Year
-1.79%
2 Year
-17.72%
5 Year
-57.86%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) -17.73 0.94 5.27 13.94 7.15 8.97 10.19 3.15 -11.68
Return on Capital Employed (%) -16.13 2.06 5.38 14.16 9.57 8.92 12.42 6.28 -5.20
Return on Assets (%) -11.11 0.55 3.27 7.39 3.15 3.70 4.67 1.78 -7.11

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 9 9 9 10 11 17 32 36 30
Non Curr. Liab. 0 0 0 0 8 5 6 6 5
Curr. Liab. 6 6 5 12 7 19 15 11 16
Minority Int.
Equity & Liab. 15 14 14 23 26 41 53 53 51
Non Curr. Assets 13 13 12 11 10 16 25 29 30
Curr. Assets 2 2 2 12 16 26 28 23 21
Misc. Exp. not W/O
Total Assets 15 14 14 23 26 41 53 53 51

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 4 7 8 14 15 24 29 31 23
Other Income 0 0 0 0 0 0 0 3 4
Total Income 4 7 8 14 15 24 29 34 27
Total Expenditure -5 -7 -7 -11 -13 -21 -24 -30 -28
PBIDT -1 1 1 3 3 3 6 4 -1
Interest 0 0 0 -1 -1 -2 -2 -2
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation 0 0 0 0 0 0 -1 0 0
Exceptional Items
PAT -2 0 0 1 1 1 2 1 -4

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 -4 -3 3 -5 3 1
Cash Fr. Inv. 0 0 0 0 0 -4 -11 -6 -2
Cash Fr. Finan. 0 0 4 3 6 11 1 0
Net Change 0 0 0 0 5 -4 -1 -1
Cash & Cash Eqvt 0 0 0 0 0 6 2 1 0

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 38.14 38.14 38.14 38.14 38.14 31.48 31.48 35.29 35.29
Public 61.86 61.86 61.86 61.86 61.86 68.52 68.52 64.71 64.71
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Tue, 20 Jul 2021
Shareholding for the Period Ended June 30 2021
Vista Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here
Tue, 20 Jul 2021
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
With reference to the above mentioned subject matter please find enclosed herewith certificate issued by Aarthi Consultants Private Limited Registrar and Share transfer Agent confirming the compliance of regulation 74 (5) of SEBI (Depository and Participants) Regulations 2018 for the period from 01.04.2021 to 30.06.2021.
Mon, 19 Jul 2021
Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0000
Name of the Signatory :- AKASH BHAGADIA
Designation :- Company Secretary and Compliance Officer

Technical Scans View Details

Fri, 23 Jul 2021
Stock Underperforming Benchmark Index in both 1 Week and 3 Month Stock Underperforming Benchmark Index in both 1 Week and 3 Month
Stock Underperforming Sectoral Index in both 1 Week and 3 Month Stock Underperforming Sectoral Index in both 1 Week and 3 Month
Strongly Underperforming Benchmark index Strongly Underperforming Benchmark index
Strongly Underperforming Sectoral index Strongly Underperforming Sectoral index
Both SRS And ARS Below Zero Both SRS And ARS Below Zero

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 166,513.85 699.50 +0.8%
Divi's Laboratories Ltd. 128,088.59 4,875.55 +1.1%
Dr. Reddy's Laboratories Ltd. 90,175.51 5,429.95 +0.1%
Cipla Ltd. 76,510.04 956.35 +0.9%
Cadila Healthcare Ltd. 62,965.29 609.75 -0.9%
Aurobindo Pharma Ltd. 56,484.48 965.75 +0.2%
Apollo Hospitals Enterprise Ltd. 56,291.69 3,994.95 +2.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 57.34 699.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2021-03 64.55 4,875.55 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 46.21 5,429.95 +0.1%
Cipla Ltd. Consolidated 2021-03 31.81 956.35 +0.9%
Cadila Healthcare Ltd. Consolidated 2021-03 29.51 609.75 -0.9%
Aurobindo Pharma Ltd. Consolidated 2021-03 10.59 965.75 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 374.38 3,994.95 +2.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 3.58 699.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2021-03 13.78 4,875.55 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 5.15 5,429.95 +0.1%
Cipla Ltd. Consolidated 2021-03 4.17 956.35 +0.9%
Cadila Healthcare Ltd. Consolidated 2021-03 4.85 609.75 -0.9%
Aurobindo Pharma Ltd. Consolidated 2021-03 2.58 965.75 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.25 3,994.95 +2.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 699.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,875.55 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 5,429.95 +0.1%
Cipla Ltd. Consolidated 2020-03 0.18 956.35 +0.9%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 609.75 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 0.33 965.75 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 3,994.95 +2.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 699.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,875.55 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 5,429.95 +0.1%
Cipla Ltd. Consolidated 2020-03 10.09 956.35 +0.9%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 609.75 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.53 965.75 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 3,994.95 +2.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 699.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,875.55 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 5,429.95 +0.1%
Cipla Ltd. Consolidated 2020-03 12.53 956.35 +0.9%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 609.75 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.80 965.75 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 3,994.95 +2.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 699.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2020-03 5,394.42 4,875.55 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 5,429.95 +0.1%
Cipla Ltd. Consolidated 2020-03 17,131.99 956.35 +0.9%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 609.75 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 23,098.51 965.75 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 3,994.95 +2.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 699.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2020-03 1,376.54 4,875.55 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 5,429.95 +0.1%
Cipla Ltd. Consolidated 2020-03 1,546.98 956.35 +0.9%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 609.75 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 2,844.69 965.75 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 3,994.95 +2.0%